Journal of Cancer · 2018 · 37 citations · 22 references
MedicineMolecular BiologyOncologyGene ExpressionMetastasisMolecular OncologyCancer Cell SignalingCancer GenomicsMalignant NeoplasmsNoncoding Rna BiologyNoncoding Rna FunctionNoncoding Rna In CancerCancer-related Noncoding Rna FunctionLong Noncoding Rna RegulationLung AdenocarcinomaMap KinasesMapk SignalingMitogen-activated Protein Kinase SignalingNoncoding Rna In MetastasisNoncoding Rna-mediated Gene Regulation
Background: Lung adenocarcinoma has a strong tendency to develop into bone metastases, especially spinal metastases (SM). Long noncoding RNAs (lncRNAs) play critical roles in regulating several biological processes in cancer cells. However, the mechanisms underlying the roles of lncRNAs in the development of SM have not been elucidated to date. Methods: Clinical specimens were collected for analysis of differentially expressed lncRNAs. The Kyoto Encyclopedia of Genes and Genomes (KEGG) was used to examine the effects of these genes on pathways. RNA pull-down was utilized to identify the targeting protein of lncRNAs. The effects of lncRNA on its target were detected in A549 and SPCA-1 cells via perturbation of the lncRNA expression. Oncological behavioral changes in transfected cells and phosphorylation of kinases in the relevant pathways, with or without inhibitors, were observed. Further, tumorigenicity was found to occur in experimental nude mice. Results: LINC00852 and the mitogen-activated protein kinase (MAPK) pathway were found to be associated with SM. Moreover, the LINC00852 target S100A9 had a positive regulatory role in the progression, migration, invasion, and metastasis of lung adenocarcinoma cells, both in vitro and in vivo. Furthermore, S100A9 strongly activated the P38 and REK1/2 kinases, and slightly activated the phosphorylation of the JNK kinase in the MAPK pathway in A549 and SPCA-1 cells. Conclusion: LINC00852 targets S100A9 to promote progression and oncogenic ability in lung adenocarcinoma SM through activation of the MAPK pathway. These findings suggest a potential novel target for early intervention against SM in lung cancer.
22
Long Noncoding RNAs with Enhancer-like Function in Human Cells
Ulf Andersson Ørom, Thomas Derrien, Malte Beringer et al. · Cell · 2010 · 1.8K citations · Full text
Tony Gutschner, Monika Hämmerle, Jeff Hsu et al. · Cancer Research · 2012 · 1.6K citations
Economic burden of metastatic bone disease in the U.S.
Kathy L. Schulman, Joseph D. Kohles · Cancer · 2007 · 239 citations
S100A9 a new marker for monocytic human myeloid‐derived suppressor cells
Fei Zhao, Bastian Hoechst, Austin G. Duffy et al. · Immunology · 2012 · 221 citations · Full text
Medicine, Immunology, Oncology +15